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叠延伸 PCR 法体外定点诱变，构建 R1628Q 突变型人心脏钠离子通道真核表达
载体。经酶切和 DNA 测序验证后与心脏钠离子通道β 1 亚基质粒
pEGFP-N3-SCN1B 瞬时共同转染到 HEK293，48 小时后全细胞记录钠通道的电
生理特性。 
结果  
1. DNA 测序证实突变质粒 pHL-hH1-R1628Q 构建成功。 
2. hH1-R1628Q 钠通道的平均峰值电流密度 (-298.7±27.0pA/pF；n=22) 与
hH1-WT 的平均峰值电流密度(-336.7±26.9pA/pF；n=30)相比，无显著性差异
(P>0.05)。hH1-R1628Q 钠通道的电导-电压(g-v)曲线与 hH1-WT 相似，V1/2 和
斜率因子 k 的统计学处理无显著差异（P>0.05）。 
3. hH1-R1628Q 钠电流的衰减时间常数在测试电压（-50mV 到 0mV）明显快
于 hH1-WT（P<0.05）。相比 hH1-WT，hH1-R1628Q 钠通道的稳态失活曲线向
负 电 位 方 向 移 动 约 20.6mV ， 统 计 学 处 理 有 显 著 差 异 (hH1- 
WT:-81.1±1.3mV,n=13;hH1-R1628Q:-101.7±1.2,n=18;P<0.05)。 
4. 经一定间隔时间-20mV 预刺激后细胞进入中间失活状态，可以得到中间失
活的时间依赖性曲线。发现 hH1-WT 和 hH1-R1628Q 的失活通道比例在各时间
下均有显著性差异，如经 1000ms 电压为-20mV 的预刺激后 R1628Q 进入中间
失活状态的比例明显提高，是 WT 的 3.6 倍（hH1-WT:19.6±1.5%, n=9; versus 















3.2±0.2ms, n=11; hH1-R1628Q: 22.5±1.0ms, n=12, P<0.05)和慢恢复时间常数τs 
(hH1-WT:104.1±20ms, n=11; hH1-R1628Q:139.0±14.0ms, n=12, P>0.05) 。
hH1-R1628Q 与 hH1-WT 相比，快恢复时间常数τf 明显延长，而慢恢复时间
常数τs 差异无统计学意义。  
结论 






















To explore the functional effect of R1628Q mutation on SCN5A,we construct 
human cardiac sodium channel alpha subunit cDNA(hH1) mutated recombinant 
pHL-hH1-R1628Q via site-directed mutagenesis in vitro, and study the current and 
electrophysiological properties of the sodium channel using patch-clamp whole-cell 
recording in HEK293 cell into which the hH1-WT or hH1-R1628Q is transfected. 
These studies can further clarify the pathogenesis of the disease and provide new 
ideas for molecular diagnosis and gene therapy.  
Method 
We design primers that include mutation base. cDNA encoding alpha subunit of  
the human cardiac sodium channel is used as a template for site-directed mutagenesis 
by overlap extension PCR method in vitro, then construct the pHL-hH1-R1628Q. The 
recombinant plasmid is verified by enzyme digestion and DNA sequencing. The 
plasmid and plasmid pEGFP-N3-SCN1B encoding cardiac sodium channel beta1 
subunit are transiently transfected into HEK293 cell lines. 48 hours after transfection, 
the whole-cell patch-clamp recording is used to study the electrophysiological 
properties and current of sodium channels. 
Result 
1. Site-mutagenesis in the pHL-hH1-R1628Q was confirmed by DNA 
sequencing. 
2．On average, no significant difference was observed between peak current 
density or the midpoint of conductance-voltage curve for hH1-WT and hH1-R1628Q.  
The peak current density of cells expressing hH1-R1628Q was similar to the those 
expressing hH1-WT (hH1-WT:-336.7±26.9pA/pF;n=30; hH1-R1628Q: 
-298.7±27.0pA/pF;n=22; P>0.05).The conductance-voltage curve of hH1-R1628Q 
channels was shifted 2.3mV toward more negative potentials compared with hH1-WT 
(hH1-WT:34.5±1.5mV,n=8;hH1-R1628Q:32.2±1.4,n=11; P>0.05). 
3. Cells expressing hH1-R1628Q exhibited a midpoint (V1/2) of the steady-state 
















time courses of current decay were faster for the R1628Q mutant compared to WT 
during the test potential range from -50mV to 0mV.The differences had statistical 
significance(P<0.05). 
4. Using a two-pusle protocol to characterize the development of intermidate 
currents(IM), with progressively longer prepusle duration, sodium current diminished 
more in cells expressing hH1-R1628Q than those transfected with hH1-WT. The 
differences between hH1-WT and hH1-R1628Q are significant at all prepulse 
durations at the level of P<0.05. At a prepusle duration of 1000ms, the proportional 
decrement in channel availability was 3.6-fold greater for R1628Q compared with 
hH1-WT (hH1-WT 19.6±1.5%, n=9; versus hH1-R1628Q 69.6±1.4%, n=8, P<0.05). 
5. The recovery from inactivation curves for hH1-WT and hH1-R1628Q have 
been fit with two exponential components where the fast time constantτf(hH1-WT: 
3.2±0.2ms, n=11; hH1-R1628Q: 22.5±1.0ms, n=12, P<0.05) and the slow time 
constantτ s (hH1-WT: 104.1±20ms, n=11; hH1-R1628Q: 139.0±14.0ms, n=12, 
P>0.05)were acquired.  
Conclusion 
1. We have successfully constructed eukaryotic expression plasmid mutation 
R1628Q associated with Brugada syndrome. 
2. The mutation had no little effect on conductance-voltage curve and current 
density but accelerated current decay and shifted steady-state inactivation in 
hyperpolarizing direction. It dramatically enhanced into intermediate inactivation 
from the closed state and extended the fast recovery time after deactivation. These 
finding suggested that D IV S4 maybe involved in inactivation process of channel and 
a mutation underlying Brugada syndrome in the voltage-sensor of cardiac sodium 
channels can alter the biophysical properties of the channel. 
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东南亚高达 12/10000，是年龄少于 50 岁无心脏病史人群中 常见的猝死原因，
占所有心源性猝死的 4%和无结构性心脏病变患者猝死的 20% [4]。我国尚缺乏大
规模的临床研究数据，但是一些国内学者在广东省健康成人体检心电图中发现










即下斜型（type 1 ECG）、马鞍型（type 2 ECG）和圆顶型（type 3 ECG）。只有
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图 1.1 经抢救复苏后的 Brugada 综合征患者胸前导联心电图。数天内心电图
呈动态改变。箭头指向为 J 波。左图呈 1 型 ECG 表现，右侧分别是 2 型和 3 型
ECG 表现[4]。 
Figure1.1 Precordial leads of a resuscitated patient with Brugada syndrome. 
Note the dynamic ECG changes in the course of a couple of days. All 3 patterns are 
shown. Arrows denote the J-wave. The left panel shows a clear type 1 ECG. Between 
7–2-99 and 13–2-99, types 2 and 3 are shown. Calibrations are given[4]. 
3、异常心电图可呈现动态改变，具有间歇性、多变性、隐匿性、非经典部
位等特点。在药物、自主神经、发热等作用下可诱发出典型的 BrS 心电图改变[3]。 
4、该病与猝死密切相关，目前尚无有效的药物治疗方法，ICD 是公认能防
止猝死的唯一有效措施。所以根据危险分层，植入 ICD 是治疗 BrS 患者的唯一
有效手段。 
Brugada 综合征是一种常染色体不完全显性遗传病。自 Chen 等[6]通过 SSCP




SLMAP 等[7]。但钠离子通道的异常 常见，大约 11–28%的 Brugada 综合征患者
携带 SCN5A 基因的突变，且具有家族史的患者突变频率明显高于散发患者，已
经发现了 300 多个突变[8]。SCN5A 编码心脏钠离子通道 α亚基，α亚基由 4 个高
度同源结构域（DⅠ-DⅣ）通过细胞内环相连，每个结构域有 6 次跨膜片段
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